Category Archives: diagnostic article

P2-mutated Spike protein trimer variant (P2-mutant,S1/S2 cleavage site(furin cleavage sequence)-mutant,trimerization modified) vectors and SARS-CoV-2(2019nCoV) Pseudotyped virus

Products list of Spike trimer (P2-mutant, S1/S2 cleavage site (furin cleavage sequence)-mutant, trimerization modified) SARS-CoV-2 P2-mutated Spike protein trimer variant (P2-mutant, S1/S2 cleavage site(furin cleavage sequence)-mutant, trimerization modified) The world is in midst of the COVID-19 pandemic caused by SARS-CoV-2 (2019nCoV) infection. The Spike protein (S-protein) of SARS-CoV-2 (2019nCoV) mediates receptor (ACE2) binding and cell […]

Investigation of novel SARS-CoV-2 variant

Variant of Concern 202012/01Technical briefing 2 Nomenclature of variants in the UK SARS-CoV-2 variants if considered to have concerning epidemiological, immunological or pathogenic properties are raised for formal investigation. At this point they are designated Variant Under Investigation (VUI) with a year, month, and number. Following risk assessment with the relevant expert committee, they may […]

GeneMedi’s Antigens and Antibodies for COVID-19 Rapid Test and Immunoassay

PDF Download The ongoing worldwide severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic has a tremendous influence on public health. There is an urgent need for developing accurate detection technologies for COVID-19 pandemic. Several diagnostic strategies are available to identify or rule out current infection, identify people in need of care escalation, or to test […]

New variant clustering in households analysis

Summary of request This analysis uses data from the COVID-19 Infection Survey up to 21 December 2020. The analysis looks to establish whether there are patterns in the associations of different types of positives within household pairs. This analysis was undertaken by Thomas House, University of Manchester Date of publication: 29th December 2020 Contents: Data: […]

New evidence on VUI-202012/01 and review of the public health risk assessment

NOVEL VARIANT INCIDENT MANAGEMENT TEAM PUBLIC HEALTH ENGLAND WITH IMPERIAL COLLEGE, THE UNIVERSITY OF EDINBURGH, THE UNIVERSITY OF BIRMINGHAM AND THE WELLCOME SANGER INSTITUTE Update on the submission of 11/12/20 New information:1. Investigation of S gene target failure cases and new epidemiology data2. Modelling on transmissibility3. Proposed risk assessment NERVTAG is asked to▪ Note the […]

NERVTAG meetingon SARS-CoV-2 variant under investigation VUI-202012/01

New and Emerging Respiratory Virus Threats Advisory Group Note of meeting Date & Location of meeting: 11:00 –13.00 18December2020 -Via telecon only In attendance: Chair: Peter Horby (PH) NERVTAG Members: Peter Openshaw (PO), Andrew Hayward (AH),Wei Shen Lim (WSL),Julian Hiscox (JHi),John Edmunds (JE), Neil Ferguson (NF), Robert Dingwall (RD),Muge Cevik (MCe), Wendy Barclay (WB), Jim McMenamin […]

NERVTAG COVID-19 VOC communication 21122020 final

New and Emerging Respiratory Virus Threats Advisory Group Note of meeting Date & Location: 12:00 –13.30 21 December 2020 -Via telecon only In attendance: Chair: Peter Horby (PH) NERVTAG Members: Andrew Hayward (AH), Julian Hiscox (JHi), John Edmunds (JE), Neil Ferguson (NF), Wendy Barclay (WB),Wei Shen Lim (WSL), Cariad Evans (CE) SPI-M: Angela McLean (AM), Graham […]

Statement from Chief Medical Officer, Professor Chris Whitty, about new strain of COVID-19

New strain of COVID-19 reported to World Health Organization. Chief Medical Officer for England, Professor Chris Whitty, said: “As announced on Monday, the UK has identified a new variant of COVID-19 through Public Health England’s genomic surveillance.”   “As a result of the rapid spread of the new variant, preliminary modelling data and rapidly rising […]

Confirmed cases of COVID-19 variant from South Africa identified in UK

Two cases of a new SARS-CoV-2 variant, which originated in South Africa, have been identified in the UK. The 2 cases were identified in the UK on 22 December 2020 and both have been in contact with someone who has travelled from South Africa. Public Health England’s Health Protection Teams have followed up with both […]

Rapid evaluation confirms lateral flow devices effective in detecting new COVID-19 variant

Public Health England (PHE) has confirmed that lateral flow devices (LFDs) used in mass testing can detect the new COVID-19 variant. Scientists at PHE’s Porton Down laboratory have carried out a rapid evaluation using clinical and laboratory grown samples containing the VUI 202012/01 variant to test whether it can be detected by lateral flow devices (LFDs) currently in […]